Neuren Pharmaceuticals Limited

ASX:NEU Stock Report

Market Cap: AU$1.6b

Neuren Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:NEU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 May 25BuyAU$7,240,636State Street Global Advisors, Inc.Company509,746AU$14.73
16 Apr 25BuyAU$153,120Joe BasileIndividual14,500AU$10.56
15 Apr 25SellAU$1,124,679State Street Global Advisors, Inc.Company82,390AU$14.45
06 Mar 25BuyAU$68,910The Vanguard Group, Inc.Company5,462AU$12.96
06 Mar 25SellAU$7,743The Vanguard Group, Inc.Company615AU$12.59
28 Feb 25SellAU$314,054The Vanguard Group, Inc.Company23,738AU$13.23
27 Feb 25BuyAU$90,591The Vanguard Group, Inc.Company6,746AU$14.20
19 Feb 25BuyAU$3,486,024The Vanguard Group, Inc.Company204,699AU$17.03
06 Feb 25SellAU$818,997The Vanguard Group, Inc.Company58,258AU$14.06
16 Aug 24BuyAU$100,766Joe BasileIndividual6,406AU$15.73
17 Jul 24BuyAU$132,031,307Milford Asset Management, LTDCompany8,499,600AU$15.53
17 Jul 24SellAU$131,556,262Milford Asset Management, LTDCompany9,003,256AU$14.61

Insider Trading Volume

Insider Buying: NEU insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NEU?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,844,8313.1%
Private Companies12,421,91110%
Institutions26,502,45221.4%
General Public81,270,33265.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 34.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.23%
The Vanguard Group, Inc.
6,492,295AU$81.4m0.78%no data
5.17%
State Street Global Advisors, Inc.
6,412,618AU$80.4m1,100%no data
4.88%
Milford Asset Management, LTD
6,058,321AU$76.0m0%0.75%
3.51%
Cameron Richard Pty Limited
4,355,222AU$54.6m5.63%no data
2.25%
Stuart Andrew Pty. Ltd.
2,790,348AU$35.0m5.94%no data
2%
Norges Bank Investment Management
2,486,288AU$31.2m0%no data
1.95%
BlackRock, Inc.
2,421,772AU$30.4m2.78%no data
1.95%
Trevor Scott
2,414,784AU$30.3m0%no data
1.45%
Linwierik Super Pty. Limited
1,800,000AU$22.6m2.19%no data
1.28%
Smithley Super Pty. Limited
1,584,000AU$19.9m-15.3%no data
0.88%
BetaShares Capital Limited
1,087,910AU$13.6m10.2%0.04%
0.67%
First Colby Co Pty Ltd
829,200AU$10.4m10.6%no data
0.54%
Robin Congreve
671,637AU$8.4m0%no data
0.48%
Mjhft Pty Ltd
600,000AU$7.5m-20%no data
0.45%
Netwealth Investments Ltd.
560,073AU$7.0m32.9%0.05%
0.37%
Emancipayte Pty ltd
463,141AU$5.8m-1.62%no data
0.32%
Jonathan Pilcher
398,207AU$5.0m0%no data
0.31%
Jupiter Fund Management Plc
383,684AU$4.8m0%0.01%
0.21%
Patrick Donald Davies
264,634AU$3.3m0%no data
0.2%
Dimensional Fund Advisors LP
246,494AU$3.1m1.02%no data
0.17%
Polar Capital Holdings Plc
214,630AU$2.7m885%0.01%
0.16%
Charles Schwab Investment Management, Inc.
198,828AU$2.5m-1.64%no data
0.11%
Nordea Investment Management, AB
138,772AU$1.7m0%no data
0.097%
UBS Asset Management AG
120,016AU$1.5m0%no data
0.08%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
99,333AU$1.2m16.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/20 21:04
End of Day Share Price 2025/06/20 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neuren Pharmaceuticals Limited is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Melissa BensonBarrenjoey Markets Pty Limited
Thomas WakimBell Potter